75 results on '"Trieb M"'
Search Results
2. Phospholipase C (PLC) is a crucial mediator of agonist-induced smooth muscle contraction in the lower urinary tract
- Author
-
Tamalunas, A., primary, Vigodski, V., additional, Eitelberger, N., additional, Trieb, M., additional, Hu, S., additional, Rutz, B., additional, Ciotkowska, A., additional, Stief, C.G., additional, and Hennenberg, M., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Anti-inflammatory activity of small-molecule antagonists of Toll-like receptor 2 (TLR2) in mice
- Author
-
Wietzorrek, G., Drexel, M., Trieb, M., and Santos-Sierra, S.
- Published
- 2019
- Full Text
- View/download PDF
4. Decoy peptides derived from the extracellular domain of toll-like receptor 2 (TLR2) show anti-inflammatory properties
- Author
-
Ebner, S., Trieb, M., Schönfeld, M., Wietzorrek, G., and Santos-Sierra, S.
- Published
- 2018
- Full Text
- View/download PDF
5. TOOLS FOR CLASSIFICATION OF MINE LIKE OBJECTS IN SYNTHETIC APERTURE SONAR IMAGES
- Author
-
ENGSTRÖM, J, primary, TRIEB, M, additional, and SHIPPEY, GA, additional
- Published
- 2023
- Full Text
- View/download PDF
6. A1015 - Novel concepts of post-receptor signaling: Phospholipase C (PLC) plays an important role in prostate cell proliferation, viability, and cytoskeletal organization
- Author
-
Tamalunas, A., Vigodski, V., Eitelberger, N., Trieb, M., Rutz, B., Chiotkowska, A., Stief, C.G., and Hennenberg, M.
- Published
- 2024
- Full Text
- View/download PDF
7. A1001 - Phospholipase C (PLC) is a crucial mediator of agonist-induced smooth muscle contraction in the lower urinary tract
- Author
-
Tamalunas, A., Vigodski, V., Eitelberger, N., Trieb, M., Hu, S., Rutz, B., Ciotkowska, A., Stief, C.G., and Hennenberg, M.
- Published
- 2024
- Full Text
- View/download PDF
8. Atrial Fibrillation Is Associated With Alterations In Hdl Function, Metabolism And Particle Number
- Author
-
Marsche, G., primary, Kornej, J., additional, Trieb, M., additional, and Buettner, P., additional
- Published
- 2019
- Full Text
- View/download PDF
9. P310HDL-function in atrial fibrillation
- Author
-
Buettner, P, primary, Trieb, M, additional, Marsche, G, additional, Hindricks, G, additional, Arya, A, additional, Sommer, P, additional, Dinov, B, additional, Bollmann, A, additional, Husser, D, additional, and Kornej, J, additional
- Published
- 2018
- Full Text
- View/download PDF
10. Liver disease alters high-density lipoprotein composition, metabolism and function
- Author
-
Trieb, M., primary, Stadlbauer, V., additional, Birner-Gruenberger, R., additional, and Marsche, G., additional
- Published
- 2016
- Full Text
- View/download PDF
11. Track-before-detect algorithm for tracking extended targets
- Author
-
Boers, Y., primary, Driessen, H., additional, Torstensson, J., additional, Trieb, M., additional, Karlsson, R., additional, and Gustafsson, F., additional
- Published
- 2006
- Full Text
- View/download PDF
12. Cooperative effects on the formation of intercalation sites
- Author
-
Trieb, M., primary
- Published
- 2004
- Full Text
- View/download PDF
13. SOLUTION STRUCTURE OF HONGOTOXIN 1
- Author
-
Pragl, B., primary, Koschak, A., additional, Trieb, M., additional, Obermair, G., additional, Kaufmann, W.A., additional, Gerster, U., additional, Blanc, E., additional, Hahn, C., additional, Prinz, H., additional, Schutz, G., additional, Darbon, H., additional, Gruber, H.J., additional, and Knaus, H.G., additional
- Published
- 2003
- Full Text
- View/download PDF
14. Synthesis, Characterization, and Application of Cy-Dye- and Alexa-Dye-Labeled Hongotoxin<INF>1</INF> Analogues. The First High Affinity Fluorescence Probes for Voltage-Gated K<SUP>+</SUP> Channels
- Author
-
Pragl, B., Koschak, A., Trieb, M., Obermair, G., Kaufmann, W. A., Gerster, U., Blanc, E., Hahn, C., Prinz, H., Schutz, G., Darbon, H., Gruber, H. J., and Knaus, H.-G.
- Abstract
Hongotoxin
1 (HgTX1 ), a 39-residue peptide recently isolated from the venom of Centruroides limbatus, blocks the voltage-gated K+ channels Kv 1.1, Kv 1.2, and Kv 1.3 at picomolar toxin concentrations (Koschak, A., Bugianesi, R. M., Mitterdorfer, J., Kaczorowski, G. J., Garcia, M. L., and Knaus, H. G. (1998) J. Biol. Chem. 273, 2639−2644). In this report, we determine the three-dimensional structure of HgTX1 using NMR spectroscopy (PDB-code: 1HLY). HgTX1 was found to possess a structure similar to previously characterized K+ channel toxins (e.g. margatoxin) consisting of a three-stranded antiparallel β-sheet (residues 2−4, 26−30, and 33−37) and a helical conformation (part 310 helix and part α helix; residues 10−20). Due to the importance of residue Lys-28 for high-affinity interaction with the respective channels, lysine-reactive fluorescence dyes cannot be used to label wild-type HgTX1 . On the basis of previous studies (see above) and our NMR data, a HgTX1 mutant (HgTX1 -A19C) was engineered, expressed, and purified. HgTX1 -A19C-SH was labeled using sulfhydryl-reactive Cy3-, Cy5-, and Alexa-dyes. Pharmacological characterization of fluorescently labeled HgTX1 -A19C in radioligand binding studies indicated that these hongotoxin1 analogues retain high-affinity for voltage-gated K+ channels and a respective pharmacological profile. Cy3- and Alexa-dye-labeled hongotoxin1 analogues were used to investigate the localization of K+ channels in brain sections. The distribution of toxin binding closely follows the distribution of Kv 1.2 immunoreactivity with the highest expression levels in the cerebellar Purkinje cell layer. Taken together, these results demonstrate that fluorescently labeled HgTX1 analogues comprise novel probes to characterize a subset of voltage-gated K+ channels.- Published
- 2002
- Full Text
- View/download PDF
15. Erratum: Dynamics of DNA: BI and BII phosphate backbone transitions (Journal of Physical Chemistry B (2004) 108B (2474))
- Author
-
Trieb, M., Rauch, C., Wellenzohn, B., Wibowo, F., Thomas Loerting, and Liedl, K. R.
16. Pubertal stage differences in hormonal and hematological responses to maximal exercise in males
- Author
-
Fahey, T. D., primary, Del Valle-Zuris, A., additional, Oehlsen, G., additional, Trieb, M., additional, and Seymour, J., additional
- Published
- 1979
- Full Text
- View/download PDF
17. The clearing of sewage waters (especially wash) in yeast factories by means of ionexes.
- Author
-
TRIEB, M., primary
- Published
- 1956
- Full Text
- View/download PDF
18. Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.
- Author
-
Tamalunas A, Wendt A, Springer F, Vigodski V, Trieb M, Eitelberger N, Poth H, Ciotkowska A, Rutz B, Hu S, Schulz H, Ledderose S, Rogenhofer N, Kolben T, Nössner E, Stief CG, and Hennenberg M
- Subjects
- Humans, Animals, Swine, Male, Thalidomide pharmacology, Thalidomide analogs & derivatives, Muscle, Smooth drug effects, Immunomodulating Agents pharmacology, Cells, Cultured, Apoptosis drug effects, Cell Survival drug effects, Lenalidomide pharmacology, Muscle Contraction drug effects, Cell Proliferation drug effects, Urinary Bladder drug effects, Myocytes, Smooth Muscle drug effects
- Abstract
Background: The immunomodulatory imide drugs (IMiDs) thalidomide, lenalidomide and pomalidomide may exhibit therapeutic efficacy in the prostate. In lower urinary tract symptoms (LUTS), voiding and storage disorders may arise from benign prostate hyperplasia, or overactive bladder. While current therapeutic options target smooth muscle contraction or cell proliferation, side effects are mostly cardiovascular. Therefore, we investigated effects of IMiDs on human detrusor and porcine artery smooth muscle contraction, and growth-related functions in detrusor smooth muscle cells (HBdSMC)., Methods: Cell viability was assessed by CCK8, and apoptosis and cell death by flow cytometry in cultured HBdSMC. Contractions of human detrusor tissues and porcine interlobar and coronary arteries were induced by contractile agonists, or electric field stimulation (EFS) in the presence or absence of an IMID using an organ bath. Proliferation was assessed by EdU assay and colony formation, cytoskeletal organization by phalloidin staining, RESULTS: Depending on tissue type, IMiDs inhibited cholinergic contractions with varying degree, up to 50 %, while non-cholinergic contractions were inhibited up to 80 % and 60 % for U46619 and endothelin-1, respectively, and EFS-induced contractions up to 75 %. IMiDs reduced viable HBdSM cells in a time-dependent manner. Correspondingly, proliferation was reduced, without showing pro-apoptotic effects. In parallel, IMiDs induced cytoskeletal disorganization., Conclusions: IMiDs exhibit regulatory functions in various smooth muscle-rich tissues, and of cell proliferation in the lower urinary tract. This points to a novel drug class effect for IMiDs, in which the molecular mechanisms of action of IMiDs merit further consideration for the application in LUTS., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Thomas Kolben holds stock of Roche AG and a relative is employed at Bayer AG. The other authors have no conflict of interest to declare., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
- Author
-
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, and Hennenberg M
- Subjects
- Male, Humans, Animals, Swine, Urinary Bladder, Death-Associated Protein Kinases pharmacology, Muscle Contraction, Prostate, Muscle, Smooth, Vascular, Biphenyl Compounds, Proto-Oncogene Proteins c-pim-1, Thiazolidines
- Abstract
Smooth muscle contraction by Pim kinases and ZIPK has been suggested, but evidence for lower urinary tract organs or using Pim-selective inhibitor concentrations is not yet available. Here, we assessed effects of the Pim inhibitors AZD1208 and TCS PIM-1 and the dual ZIPK/Pim inhibitor HS38 on contractions of human prostate and bladder tissues and of porcine interlobar arteries. Human tissues were obtained from radical prostatectomy and radical cystectomy and renal interlobar arteries from pigs. Contractions were studied in an organ bath. Noradrenaline-, phenylephrine- and methoxamine-induced contractions were reduced (up to > 50%) with 500-nM AZD1208 in prostate tissues and to lesser degree and not consistently with all agonists in interlobar arteries. A total of 100-nM AZD1208 or 500-nM TCS PIM-1 did not affect agonist-induced contractions in prostate tissues. Decreases in agonist-induced contractions with 3-µM HS38 in prostate tissues and interlobar arteries were of small extent and did not occur with each agonist. Carbachol-induced contractions in detrusor tissues were unchanged with AZD1208 (500 nM) or HS38. Electric field stimulation-induced contractions were not affected with AZD1208 or HS38 in any tissue, but slightly reduced with 500-nM TCS PIM-1 in prostate tissues. Concentration-dependent effects of Pim inhibitors suggest lacking Pim-driven smooth muscle contraction in the prostate, bladder, and interlobar arteries but point to organ-specific functions of off-targets. Procontractile functions of ZIPK in the prostate and interlobar arteries may be limited and are lacking in the detrusor., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
- Author
-
Liu Y, Wang R, Huang R, Rutz B, Ciotkowska A, Tamalunas A, Hu S, Trieb M, Waidelich R, Strittmatter F, Stief CG, and Hennenberg M
- Abstract
Background: NUAKs promote myosin light chain phosphorlyation, actin organization, proliferation and suppression of cell death in non-muscle cells, which are critical for smooth muscle contraction and growth. In benign prostatic hyperplasia (BPH), contraction and growth in the prostate drive urethral obstruction and voiding symptoms. However, a role of NUAKs in smooth muscle contraction or prostate functions are unknown. Here, we examined effects of NUAK silencing and the presumed NUAK inhibitors, HTH01-015 and WZ4003 on contraction and growth-related functions in prostate stromal cells (WPMY-1) and in human prostate tissues. Methods: Effects of NUAK1 and -2 silencing, HTH01-015 and WZ4003 on matrix plug contraction, proliferation (EdU assay, Ki-67 mRNA), apoptosis and cell death (flowcytometry), viability (CCK-8) and actin organization (phalloidin staining) were examined in cultured WPMY-1 cells. Effects of HTH01-015 and WZ4003 on smooth muscle contraction were assessed in organ bath experirments with human prostate tissues. Results: Effects of silencing were most pronounced on proliferation and cell death, resulting in decreases of proliferation rate by 60% and 70% by silencing of NUAK1 and NUAK2 (compared to scramble siRNA-transfected controls), decreases in Ki-67 by 75% and 77%, while numbers of dead cells after silencing of NUAK1 and NUAK2 amounted to 2.8 and 4.9 fold of scramble-transfected controls. Silencing of each isoform was paralleled by reduced viability, breakdown in actin polymerization, and partial decreases in contractility (maximally 45% by NUAK1 silencing, 58% by NUAK2 silencing). Effects of silencing were mimicked by HTH01-015 and WZ4003, with numbers of dead cells amounting up to 16.1 fold or 7.8 fold with HTH01-015 or WZ4003, compared to solvent-treated controls. Using concentrations of 500 nM, neurogenic contractions of prostate tissues were inhibited partly by HTH01-015 and U46619-induced contractions were inhibited partly by HTH01-015 and WZ4003, while α
1 -adrenergic and endothelin-1-induced contractions remained unaffected. Using 10 μM, inhibition of endothelin-1-induced contractions by both inhibitors and inhibition of α1 -adrenergic contractions by HTH01-015 added to effects seen by 500 nM. Conclusion: NUAK1 and -2 suppress cell death and promote proliferation in prostate stromal cells. A role in stromal hyperplasia appears possible in BPH. Effects of NUAK silencing are mimicked by HTH01-015 and WZ4003., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Liu, Wang, Huang, Rutz, Ciotkowska, Tamalunas, Hu, Trieb, Waidelich, Strittmatter, Stief and Hennenberg.)- Published
- 2023
- Full Text
- View/download PDF
21. Anti-inflammatory HDL effects are impaired in atrial fibrillation.
- Author
-
Holzwirth E, Fischer-Schaepmann T, Obradovic D, von Lucadou M, Schwedhelm E, Daum G, Hindricks G, Marsche G, Trieb M, Thiele H, Kornej J, and Büttner P
- Subjects
- Animals, Anti-Inflammatory Agents, Cattle, Endothelial Cells, Humans, Lipoproteins, HDL, P-Selectin, Vascular Cell Adhesion Molecule-1, Atrial Fibrillation
- Abstract
High-density lipoprotein (HDL), best known for cholesterol transport, also has anti-inflammatory effects. Previous studies suggest involvement of myeloperoxidase (MPO) in modification of HDL. HDL bound Sphingosine-1-phosphate (S1P) has been implied to be an essential protein regarding beneficial HDL effects. In this study, we analyzed anti-inflammatory HDL properties in patients with atrial fibrillation (AF), a disease involving atrial inflammation, compared to non-AF controls and whether anti-inflammatory properties improve upon catheter ablation. Additionally, association with serum concentrations of MPO and S1P were assessed. We isolated HDL from 25 AF patients, 13 non-AF individuals and 14 AF patients at follow-up (FU) after catheter ablation. S1P was measured in a cohort of 141 AF and 21 FU patients. Following preincubation with HDL from either group, bovine aortic endothelial cells were stimulated using tumor necrosis factor α and expression of pro-inflammatory genes intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1), E-selectin (SELE) and P-selectin (SELP) was assessed using qPCR. Concentrations of circulating protein of these genes as well as MPO and S1P were measured in serum samples. Compared to non-AF individuals HDL from AF patients suppressed gene expression of the pro-inflammatory adhesion molecules ICAM1, VCAM1, SELE and SELP 27%, 18%, 21% and 57% less, respectively (p < 0.05 for all except SELE p = 0.06). In FU patients, the anti-inflammatory HDL activity was improved (suppression of ICAM1 + 22%, VCAM1 + 10%, SELE + 38% and SELP + 75%, p < 0.05 for all except VCAM1 p = 0.08). AF patients using angiotensin converting enzyme inhibitors or angiotensin receptor blockers had better anti-inflammatory HDL properties than non-users (gene expression suppression at least 28% more, p < 0.05 for all except ICAM1 p = 0.051). Circulating protein concentrations were not correlated with in vitro gene-expression, but circulating P-selectin was generally elevated in AF and FU patients compared to non-AF patients. MPO plasma concentration was positively associated with gene-expression of ICAM1, VCAM1 and SELP (r
2 > 0.4, p < 0.05). Serum concentrations of S1P were increased in FU patients {1.201 µM [1.077-1.543]} compared to AF patients {0.953 µM [0.807-1.135], p < 0.01} but not correlated with ICAM1, VCAM1 and SELP gene expression. We conclude that the anti-inflammatory activity of HDL is impaired in AF patients, which might promote AF progression and AF-associated complications., (© 2021. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
22. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study.
- Author
-
Horvath A, Leber B, Feldbacher N, Tripolt N, Rainer F, Blesl A, Trieb M, Marsche G, Sourij H, and Stadlbauer V
- Subjects
- Biomarkers, Double-Blind Method, Glucose, Humans, Lipids, Permeability, Pilot Projects, Quality of Life, Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Probiotics, Synbiotics
- Abstract
Purpose: Diabesity, the combination of obesity and type 2 diabetes, is an ever-growing global health burden. Diabesity-associated dysbiosis of the intestinal microbiome has gained attention as a potential driver of disease and, therefore, a possible therapeutic target by means of pro- or prebiotic supplementation. This study tested the effects of a multispecies synbiotic (i.e. a combination of probiotics and prebiotics) on glucose metabolism, gut microbiota, gut permeability, neutrophil function and quality of life in treatment-experienced diabesity patients., Methods: A randomized, double-blind, placebo-controlled pilot study with 26 diabesity patients was conducted in which patients received a daily dose of a multispecies probiotic and a prebiotic (or a placebo) for 6 months., Results: There were no changes in glucose metabolism or mixed meal tolerance test responses throughout the study. The analysis of secondary outcomes revealed beneficial effects on hip circumference [- 1 (95% CI - 4; 3) vs +3 (- 1; 8) cm, synbiotics vs. placebo, respectively, p = 0.04], serum zonulin [- 0.04 (- 0.2; 0.1) vs +0.3 (- 0.05; 0.6) ng/ml, p = 0.004)] and the physical role item of the SF36 quality of life assessment [+ 5.4 (- 1.7; 12.5) vs - 5.0 (- 10.1; 0.2) points, p = 0.02] after 3 months of intervention, and lipoprotein (a) [- 2.1 (- 5.7; 1.6) vs +3.4 (- 0.9; 7.9) mg/dl, p = 0.02] after 6 months. There were no significant differences in alpha or beta diversity of the microbiome between groups or time points., Conclusions: Glucose metabolism as the primary outcome was unchanged during the intervention with a multispecies synbiotic in patients with diabesity. Nevertheless, synbiotics improved some symptoms and biomarkers of type 2 diabetes and aspects of quality of life suggesting a potential role as adjuvant tool in the management of diabesity.
- Published
- 2020
- Full Text
- View/download PDF
23. Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity.
- Author
-
Trakaki A, Scharnagl H, Trieb M, Holzer M, Hinghofer-Szalkay H, Goswami N, and Marsche G
- Subjects
- Adult, Aryldialkylphosphatase blood, Cholesterol Ester Transfer Proteins blood, Cholesterol, HDL blood, Humans, Male, Phosphatidylcholine-Sterol O-Acyltransferase blood, Bed Rest, Cholesterol blood, Lipoproteins, HDL blood
- Abstract
Recent observations strongly connect high-density lipoproteins (HDL) function and levels with coronary heart disease outcomes and risk for infections and sepsis. To date, our knowledge of factors determining this connection is still very limited. The immobility associated with prolonged bedrest is detrimental to health, affecting several systems, including the cardiovascular, pulmonary, gastrointestinal, musculoskeletal and urinary. Effects of prolonged bedrest on the composition and functional properties of HDL remain elusive. We evaluated metrics of HDL composition and function in healthy male volunteers participating in a randomized, crossover head-down bedrest study. We observed that HDL cholesterol efflux capacity was profoundly decreased during bedrest, mediated by a bedrest associated reduction in plasma levels of HDL-cholesterol and major apolipoproteins (apo) apoA-I and apoA-II. Paraoxonase activity, plasma anti-oxidative capacity and the activities of lecithin-cholesterol acyltransferase and cholesteryl ester transfer protein were not affected. No change was observed in the content of HDL-associated serum amyloid A, a sensitive marker of inflammation. Resistive vibration exercise countermeasure during bedrest did not correct impaired cholesterol efflux capacity and only tended to increase arylesterase activity of HDL-associated paraoxonase. In conclusion, prolonged bedrest reduces plasma HDL levels linked to markedly suppressed HDL cholesterol efflux capacity. Resistive vibration exercise during bedrest did not correct HDL levels and impaired cholesterol efflux capacity.
- Published
- 2020
- Full Text
- View/download PDF
24. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
- Author
-
Trieb M, Rainer F, Stadlbauer V, Douschan P, Horvath A, Binder L, Trakaki A, Knuplez E, Scharnagl H, Stojakovic T, Heinemann Á, Mandorfer M, Paternostro R, Reiberger T, Pitarch C, Amorós A, Gerbes A, Caraceni P, Alessandria C, Moreau R, Clària J, Marsche G, and Stauber RE
- Subjects
- Biomarkers, Cross-Sectional Studies, Disease Progression, Europe epidemiology, Female, Humans, Male, Middle Aged, Organ Dysfunction Scores, Predictive Value of Tests, Prognosis, Severity of Illness Index, Acute-On-Chronic Liver Failure blood, Acute-On-Chronic Liver Failure diagnosis, Acute-On-Chronic Liver Failure epidemiology, Acute-On-Chronic Liver Failure metabolism, Apolipoprotein A-I blood, Apolipoprotein A-I metabolism, Cholesterol, HDL blood, Cholesterol, HDL metabolism, Lipoproteins, HDL2 blood, Lipoproteins, HDL2 metabolism, Lipoproteins, HDL3 blood, Lipoproteins, HDL3 metabolism, Liver Cirrhosis blood, Liver Cirrhosis diagnosis, Liver Cirrhosis epidemiology
- Abstract
Background & Aims: High-density lipoprotein cholesterol (HDL-C) levels are reduced in patients with chronic liver disease and inversely correlate with disease severity. During acute conditions such as sepsis, HDL-C levels decrease rapidly and HDL particles undergo profound changes in their composition and function. We aimed to determine whether indices of HDL quantity and quality associate with progression and survival in patients with advanced liver disease., Methods: HDL-related biomarkers were studied in 508 patients with compensated or decompensated cirrhosis (including acute-on-chronic liver failure [ACLF]) and 40 age- and gender-matched controls. Specifically, we studied levels of HDL-C, its subclasses HDL2-C and HDL3-C, and apolipoprotein A1 (apoA-I), as well as HDL cholesterol efflux capacity as a metric of HDL functionality., Results: Baseline levels of HDL-C and apoA-I were significantly lower in patients with stable cirrhosis compared to controls and were further decreased in patients with acute decompensation (AD) and ACLF. In stable cirrhosis (n = 228), both HDL-C and apoA-I predicted the development of liver-related complications independently of model for end-stage liver disease (MELD) score. In patients with AD, with or without ACLF (n = 280), both HDL-C and apoA-I were MELD-independent predictors of 90-day mortality. On ROC analysis, both HDL-C and apoA-I had high diagnostic accuracy for 90-day mortality in patients with AD (AUROCs of 0.79 and 0.80, respectively, similar to that of MELD 0.81). On Kaplan-Meier analysis, HDL-C <17 mg/dl and apoA-I <50 mg/dl indicated poor short-term survival. The prognostic accuracy of HDL-C was validated in a large external validation cohort of 985 patients with portal hypertension due to advanced chronic liver disease (AUROCs HDL-C: 0.81 vs. MELD: 0.77)., Conclusion: HDL-related biomarkers are robust predictors of disease progression and survival in chronic liver failure., Lay Summary: People who suffer from cirrhosis (scarring of the liver) have low levels of cholesterol carried by high-density lipoproteins (HDL-C). These alterations are connected to inflammation, which is a problem in severe liver disease. Herein, we show that reduced levels of HDL-C and apolipoprotein A-I (apoA-I, the main protein carried by HDL) are closely linked to the severity of liver failure, its complications and survival. Both HDL-C and apoA-I can be easily measured in clinical laboratories and are as good as currently used prognostic scores calculated from several laboratory values by complex formulas., Competing Interests: Conflicts of interest Alexander Gerbes received personal fees from CSL Behring, GRIFOLS, and Falk. All other authors declare that they have no conflicts of interest related to the study. Please refer to the accompanying ICMJE disclosure forms for further details., (Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Lysophosphatidylcholines inhibit human eosinophil activation and suppress eosinophil migration in vivo.
- Author
-
Knuplez E, Curcic S, Theiler A, Bärnthaler T, Trakaki A, Trieb M, Holzer M, Heinemann A, Zimmermann R, Sturm EM, and Marsche G
- Subjects
- Animals, CD11b Antigen metabolism, Cells, Cultured, Eosinophils metabolism, Eosinophils physiology, Humans, Membrane Microdomains metabolism, Mice, Mice, Inbred BALB C, Chemotaxis, Eosinophils drug effects, Hypersensitivity metabolism, Lysophosphatidylcholines pharmacology
- Abstract
Eosinophils are important multifaceted effector cells involved in allergic inflammation. Following allergen challenge, eosinophils and other immune cells release secreted phospholipases, generating lysophosphatidylcholines (LPCs). LPCs are potent lipid mediators, and serum levels of LPCs associate with asthma severity, suggesting a regulatory activity of LPCs in asthma development. As of yet, the direct effects of LPCs on eosinophils remain unclear. In the present study, we tested the effects of the major LPC species (16:0, 18:0 and 18:1) on eosinophils isolated from healthy human donors. Addition of saturated LPCs in the presence of albumin rapidly disrupted cholesterol-rich nanodomains on eosinophil cell membranes and suppressed multiple eosinophil effector responses, such as CD11b upregulation, degranulation, chemotaxis, and downstream signaling. Furthermore, we demonstrate in a mouse model of allergic cell recruitment, that LPC treatment markedly reduces immune cell infiltration into the lungs. Our observations suggest a strong modulatory activity of LPCs in the regulation of eosinophilic inflammation in vitro and in vivo., Competing Interests: Declaration of competing interest All authors declare no conflicts of interest., (Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. The Path Towards a Tailored Clinical Biosimilar Development.
- Author
-
Schiestl M, Ranganna G, Watson K, Jung B, Roth K, Capsius B, Trieb M, Bias P, and Maréchal-Jamil J
- Subjects
- Drug Approval, European Union, Humans, United States, United States Food and Drug Administration, Biosimilar Pharmaceuticals adverse effects, Biosimilar Pharmaceuticals standards, Biosimilar Pharmaceuticals therapeutic use, Drug Development standards
- Abstract
Since the first approval of a biosimilar medicinal product in 2006, scientific understanding of the features and development of biosimilar medicines has accumulated. This review scrutinizes public information on development programs and the contribution of the clinical studies for biosimilar approval in the European Union (EU) and/or the United States (US) until November 2019. The retrospective evaluation of the programs that eventually obtained marketing authorization and/or licensure revealed that in 95% (36 out of 38) of all programs, the comparative clinical efficacy studies confirmed similarity. In the remaining 5% (2 out of 38), despite meeting efficacy outcomes, the biosimilar candidates exhibited clinical differences in immunogenicity that required changes to the manufacturing process and additional clinical studies to enable biosimilar approval. Both instances of clinical differences in immunogenicity occurred prior to 2010, and the recurrence of these cases is unlikely today due to state-of-the-art assays and improved control of process-related impurities. Biosimilar candidates that were neither approved in the EU nor in the US were not approved due to reasons other than clinical confirmation of efficacy. This review of the development history of biosimilars allows the proposal of a more efficient and expedited biosimilar development without the routine need for comparative clinical efficacy and/or pharmacodynamic studies and without any compromise in quality, safety, or efficacy. This proposal is scientifically valid, consistent with regulation of all biologics, and maintains robust regulatory standards in the assessment of biosimilar candidates. Note: The findings and conclusion of this paper are limited to biosimilar products developed against the regulatory standards in the EU and the US.
- Published
- 2020
- Full Text
- View/download PDF
27. Endothelial lipase increases eNOS activating capacity of high-density lipoprotein.
- Author
-
Radulović S, Gottschalk B, Hörl G, Zardoya-Laguardia P, Schilcher I, Hallström S, Vujić N, Schmidt K, Trieb M, Graier WF, Malli R, Kratky D, Marsche G, and Frank S
- Subjects
- Cell Line, Cell Membrane metabolism, Cholesterol metabolism, Enzyme Activation, Hep G2 Cells, Humans, Phosphorylation, Vasodilation, Lipase metabolism, Lipoproteins, HDL metabolism, Nitric Oxide Synthase Type III metabolism
- Abstract
Endothelial lipase (EL) changes structural and functional properties of high-density lipoprotein (HDL). HDL is a relevant modulator of endothelial nitric oxide synthase (eNOS) activity, but the effect of EL on HDL induced eNOS-activation has not yet been investigated. Here, we examined the impact of EL-modified HDL (EL-HDL) on eNOS activity, subcellular trafficking, and eNOS- dependent vasorelaxation. EL-HDL and empty virus (EV)-HDL as control were isolated from human serum incubated with EL-overexpressing or EV infected HepG2 cells. EL-HDL exhibited higher capacity to induce eNOS phosphorylation at Ser1177 and eNOS activity in EA.hy 926 cells, as well as eNOS-dependent vasorelaxation of mouse aortic rings compared to control HDL. As revealed by confocal and structured illumination-microscopy EL-HDL-driven induction of eNOS was accompanied by an increased eNOS-GFP targeting to the plasma membrane and a lower eNOS-GFP colocalization with Golgi and mitochondria. Widefield microscopy of filipin stained cells revealed that EL-HDL lowered cellular free cholesterol (FC) and as found by thin-layer chromatography increased cellular cholesterol ester (CE) content. Additionally, cholesterol efflux capacity, acyl-coenzyme A: cholesterol acyltransferase activity, and HDL particle uptake were comparable between EL-HDL and control HDL. In conclusion, EL increases eNOS activating capacity of HDL, a phenomenon accompanied by an enrichment of the plasma membrane eNOS pool, a decreased cell membrane FC and increased cellular CE content., Competing Interests: Declaration of competing interest The authors have no conflict of interest to disclose., (Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.
- Author
-
Trakaki A, Sturm GJ, Pregartner G, Scharnagl H, Eichmann TO, Trieb M, Knuplez E, Holzer M, Stadler JT, Heinemann A, Sturm EM, and Marsche G
- Subjects
- Adolescent, Adult, Child, Cytokines analysis, Cytokines immunology, Female, Humans, Immunoglobulin E immunology, Lipoproteins, HDL analysis, Male, Monocytes immunology, Young Adult, Lipoproteins, HDL immunology, Rhinitis, Allergic immunology
- Abstract
Despite strong evidence that high-density lipoproteins (HDLs) modulate the immune response, the role of HDL in allergies is still poorly understood. Many patients with allergic rhinitis (AR) develop a late-phase response, characterized by infiltration of monocytes and eosinophils into the nasal submucosa. Functional impairment of HDL in AR-patients may insufficiently suppress inflammation and cell infiltration, but the effect of AR on the composition and function of HDL is not understood. We used apolipoprotein (apo) B-depleted serum as well as isolated HDL from AR-patients (n = 43) and non-allergic healthy controls (n = 20) for detailed compositional and functional characterization of HDL. Both AR-HDL and apoB-depleted serum of AR-patients showed decreased anti-oxidative capacity and impaired ability to suppress monocyte nuclear factor-κB expression and pro-inflammatory cytokine secretion, such as interleukin (IL)-4, IL-6, IL-8, tumor necrosis factor alpha and IL-1 beta. Sera of AR-patients showed decreased paraoxonase and cholesteryl-ester transfer protein activities, increased lipoprotein-associated phospholipase A2 activity, while lecithin-cholesterol acyltransferase activity and cholesterol efflux capacity were not altered. Surprisingly, apoB-depleted serum and HDL from AR-patients showed an increased ability to suppress eosinophil effector responses upon eotaxin-2/CCL24 stimulation. Mass spectrometry and biochemical analyses showed reduced levels of apoA-I and phosphatidylcholine, but increased levels of apoA-II, triglycerides and lyso-phosphatidylcholine in AR-HDL. The changes in AR-HDL composition were associated with altered functional properties. In conclusion, AR alters HDL composition linked to decreased anti-oxidative and anti-inflammatory properties but improves the ability of HDL to suppress eosinophil effector responses., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
29. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.
- Author
-
Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, and Buettner P
- Subjects
- Aged, Apolipoprotein A-I blood, Aryldialkylphosphatase blood, Atrial Fibrillation diagnosis, Biomarkers blood, Case-Control Studies, Dyslipidemias diagnosis, Female, Humans, Male, Middle Aged, Particle Size, Phosphatidylcholine-Sterol O-Acyltransferase blood, Serum Amyloid A Protein metabolism, Atrial Fibrillation blood, Cholesterol, HDL blood, Dyslipidemias blood
- Abstract
Increased morbidity and mortality in atrial fibrillation (AF) are related to the pro-fibrotic, pro-thrombotic, and pro-inflammatory processes that underpin the disease. High-density lipoproteins (HDL) have anti-inflammatory, anti-oxidative, and anti-thrombotic properties. Functional impairment of HDL may, therefore, associate with AF initiation or progression. We studied indices of HDL quality and quantity of AF patients and healthy controls, including HDL-particle number, HDL cholesterol, apolipoprotein (apo) A-I levels, serum amyloid A (SAA) content and HDL-cholesterol efflux capacity, and paraoxonase activity of apoB-depleted serum. Serum samples were collected from AF patients (n = 91) before catheter ablation and from age- and sex-matched control subjects (n = 54). HDL-cholesterol efflux capacity was assessed in a validated assay using [
3 H]-cholesterol-labeled J774 macrophages. Lecithin-cholesterol acyltransferase (LCAT) and paraoxonase activities were assessed using fluorometric assays, SAA levels were determined by ELISA, and total and subclass HDL-particle number was assessed by nuclear magnetic resonance spectroscopy. ApoA-I levels were determined by immunoturbidimetry. HDL-cholesterol efflux capacity, HDL-particle number, apoA-I levels, and LCAT activity were markedly reduced in AF patients when compared to healthy individuals (all p < 0.001), whereas HDL-associated paraoxonase activity and SAA content were not altered (p = 0.578, p = 0.681). Notably, cholesterol efflux capacity, HDL-particle number, apoA-I levels as well as LCAT activity recovered following restoration of sinus rhythm (all p < 0.001). We identified marked alterations in HDL function, HDL maturation, and HDL-particle number in AF patients. Assessing HDL-particle number and function in AF may be used as a surrogate marker of AF onset and progression and may help identifying patients at high risk.- Published
- 2019
- Full Text
- View/download PDF
30. Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans.
- Author
-
Grabner GF, Fawzy N, Pribasnig MA, Trieb M, Taschler U, Holzer M, Schweiger M, Wolinski H, Kolb D, Horvath A, Breinbauer R, Rülicke T, Rabl R, Lass A, Stadlbauer V, Hutter-Paier B, Stauber RE, Fickert P, Zechner R, Marsche G, Eichmann TO, and Zimmermann R
- Subjects
- Adult, Aged, Animals, Female, Humans, Lysophospholipids blood, Male, Metabolic Diseases blood, Mice, Mice, Knockout, Mice, Transgenic, Middle Aged, Monoacylglycerol Lipases deficiency, Monoacylglycerol Lipases genetics, Monoglycerides blood, Phenotype, Lysophospholipids metabolism, Metabolic Diseases metabolism, Monoacylglycerol Lipases metabolism, Monoglycerides metabolism
- Abstract
Bis(monoacylglycerol)phosphate (BMP) is a phospholipid that is crucial for lipid degradation and sorting in acidic organelles. Genetic and drug-induced lysosomal storage disorders (LSDs) are associated with increased BMP concentrations in tissues and in the circulation. Data on BMP in disorders other than LSDs, however, are scarce, and key enzymes regulating BMP metabolism remain elusive. Here, we demonstrate that common metabolic disorders and the intracellular BMP hydrolase α/β-hydrolase domain-containing 6 (ABHD6) affect BMP metabolism in mice and humans. In mice, dietary lipid overload strongly affects BMP concentration and FA composition in the liver and plasma, similar to what has been observed in LSDs. Notably, distinct changes in the BMP FA profile enable a clear distinction between lipid overload and drug-induced LSDs. Global deletion of ABHD6 increases circulating BMP concentrations but does not cause LSDs. In humans, nonalcoholic fatty liver disease and liver cirrhosis affect the serum BMP FA composition and concentration. Furthermore, we identified a patient with a loss-of-function mutation in the ABHD6 gene, leading to an altered circulating BMP profile. In conclusion, our results suggest that common metabolic diseases and ABHD6 affect BMP metabolism in mice and humans., (Copyright © 2019 Grabner et al. Published by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
31. Abnormal composition and function of high-density lipoproteins in atopic dermatitis patients.
- Author
-
Trieb M, Wolf P, Knuplez E, Weger W, Schuster C, Peinhaupt M, Holzer M, Trakaki A, Eichmann T, Lass A, Wadsack C, Schuligoi R, Heinemann A, and Marsche G
- Subjects
- Biomarkers, Dermatitis, Atopic diagnosis, Humans, Immunomodulation, Lipid Metabolism, Lipoproteins, HDL blood, Dermatitis, Atopic immunology, Dermatitis, Atopic metabolism, Disease Susceptibility, Lipoproteins, HDL metabolism
- Published
- 2019
- Full Text
- View/download PDF
32. Shaker-related voltage-gated potassium channels Kv1 in human hippocampus.
- Author
-
Willis M, Leitner I, Seppi K, Trieb M, Wietzorrek G, Marksteiner J, and Knaus HG
- Subjects
- Aged, Animals, Autoradiography, Cell Membrane drug effects, Cell Membrane metabolism, Dose-Response Relationship, Drug, Female, Hippocampus cytology, Humans, Immunoprecipitation, Iodine Isotopes pharmacokinetics, Kv1.2 Potassium Channel metabolism, Male, Mice, Middle Aged, Scorpion Venoms pharmacokinetics, Hippocampus metabolism, Shaker Superfamily of Potassium Channels metabolism
- Abstract
In this study, we investigated the tissue expression levels, alpha subunit composition and distribution of Shaker-related voltage-dependent potassium Kv1 channels in human hippocampus by combining western blotting experiments, toxin autoradiography, in vivo radioligand binding studies, immunoprecipitation and immunohistochemistry. Tissue expression of Kv1.1 and Kv1.2 α-subunits in human post-mortem brain tissue was confirmed in immunoblot analysis using a panel of specific monoclonal and polyclonal antibodies. Immunoprecipitation experiments using toxin-prelabeled Kv1 channels revealed that all toxin-sensitive Kv1 channels in human hippocampus contained either a Kv1.1 or Kv1.2 α-subunit with the majority being composed of Kv1.1/Kv1.2 heterotetramers. Receptor autoradiography suggested Kv1.1/Kv1.2 channel expression in the molecular layer of dentate gyrus. In accordance, immunohistochemical experiments also observed Kv1.1 and Kv1.2 α-subunits in the molecular layer of the dentate gyrus, in addition to the CA3 stratum lucidum and the CA1 stratum oriens. These findings indicate expression in axons and terminals of hippocampal pathways, namely the perforant path, the mossy fiber pathway and the Schaffer collaterals. Herein we present the first direct demonstration that Kv1.1 and Kv1.2 channel proteins are targeted to distinct compartments of the human hippocampal formation and that this expression pattern largely reflects their distribution profile in murine brain.
- Published
- 2018
- Full Text
- View/download PDF
33. HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.
- Author
-
Untersteller K, Meissl S, Trieb M, Emrich IE, Zawada AM, Holzer M, Knuplez E, Fliser D, Heine GH, and Marsche G
- Subjects
- Aftercare, Aged, Cholesterol, HDL chemistry, Cohort Studies, Female, Humans, Male, Middle Aged, Cardiovascular Diseases complications, Cholesterol, HDL metabolism, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic metabolism
- Abstract
CVD remains the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). CKD profoundly affects HDL composition and functionality, but whether abnormal HDL independently contributes to cardiovascular events in CKD patients remains elusive. In the present study, we assessed whether compositional and functional properties of HDL predict cardiovascular outcome among 526 nondialysis CKD patients who participate in the CARE FOR HOMe study. We measured HDL cholesterol, the content of HDL-associated proinflammatory serum amyloid A (SAA), and activities of the HDL enzymes paraoxonase and lipoprotein-associated phospholipase A2 (Lp-PLA
2 ). In addition, we assessed the antioxidative activity of apoB-depleted serum. During a mean follow-up of 5.1 ± 2.1 years, 153 patients reached the predefined primary endpoint, a composite of atherosclerotic cardiovascular events including cardiovascular mortality and death of any cause. In univariate Cox regression analyses, lower HDL-cholesterol levels, higher HDL-associated SAA content, and lower paraoxonase activity predicted cardiovascular outcome, while Lp-PLA2 activity and antioxidative capacity did not. HDL-cholesterol and HDL-paraoxonase activity lost their association with cardiovascular outcome after adjustment for traditional cardiovascular and renal risk factors, while SAA lost its association after further adjustment for C-reactive protein. In conclusion, our data suggest that neither HDL quantity nor HDL composition or function independently predict cardiovascular outcome among nondialysis CKD patients., (Copyright © 2018 Untersteller et al. Published by The American Society for Biochemistry and Molecular Biology, Inc.)- Published
- 2018
- Full Text
- View/download PDF
34. The complex high-density lipoprotein proteome: a matter of purification?
- Author
-
Holzer M, Trieb M, and Marsche G
- Subjects
- Lipoproteins, HDL, Proteome
- Published
- 2017
- Full Text
- View/download PDF
35. HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants.
- Author
-
Holzer M, Kern S, Trieb M, Trakaki A, and Marsche G
- Subjects
- Humans, Blood Specimen Collection methods, Cryopreservation methods, Lipoproteins, HDL chemistry, Lipoproteins, HDL metabolism
- Abstract
Analysis of structural and functional parameters of HDL has gained significant momentum in recent years because they are stronger predictors of cardiovascular risk than HDL-cholesterol levels. Surprisingly, in most HDL studies, very low attention is paid to HDL storage, which might critically affect functional properties. In the present study, we systematically examined the impact of storage and freezing on the structural/functional properties of freshly isolated HDL. Initial damage to HDL starts between week 1 and week 4 of storage. We observed that prolonged freezing at -20°C or -70°C led to a shedding of apoA-I from HDL and to the formation of large protein-poor particles, indicating that HDL is irreversibly disrupted. These structural alterations profoundly affected key metrics of HDL function, including HDL-cholesterol efflux capacity and HDL paraoxonase activity. Flash-freezing of isolated HDL prior to storage at -70°C did not preserve HDL structure. However, addition of the cryoprotectants, sucrose or glycerol, completely preserved structure and function of HDL when stored for at least 2 years. Our data clearly indicate that HDL is a complex particle requiring special attention when stored. Addition of cryoprotectants to isolated HDL samples before storage will make biochemical and clinical HDL research studies more reproducible and comparable., (Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
36. Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain.
- Author
-
Willis M, Trieb M, Leitner I, Wietzorrek G, Marksteiner J, and Knaus HG
- Subjects
- Aged, Animals, Female, Humans, Immunohistochemistry, Male, Mice, Mice, Inbred C57BL, Neurons metabolism, Protein Isoforms metabolism, Small-Conductance Calcium-Activated Potassium Channels immunology, Brain metabolism, Small-Conductance Calcium-Activated Potassium Channels metabolism
- Abstract
SK2 (KCa2.2) channels are voltage-independent Ca
2+ -activated K+ channels that regulate neuronal excitability in brain regions important for memory formation. In this study, we investigated the distribution and expression of SK2 channels in human brain by Western blot analysis and immunohistochemistry. Immunoblot analysis of human brain indicated expression of four distinct SK2 channel isoforms: the standard, the long and two short isoforms. Immunohistochemistry in paraffin-embedded post-mortem brain sections was performed in the hippocampal formation, amygdala and neocortex. In hippocampus, SK2-like immunoreactivity could be detected in strata oriens and radiatum of area CA1-CA2 and in the molecular layer. In the amygdala, SK2-like immunoreactivity was highest in the basolateral nuclei, while in neocortex, staining was mainly found enriched in layer V. Activation of SK2 channels is thought to regulate neuronal excitability in brain by contributing to the medium afterhyperpolarization. However, SK2 channels are blocked by apamin with a sensitivity that suggests heteromeric channels. The herein first shown expression of SK2 human isoform b in brain could explain the variability of electrophysiological findings observed with SK2 channels.- Published
- 2017
- Full Text
- View/download PDF
37. Liver disease alters high-density lipoprotein composition, metabolism and function.
- Author
-
Trieb M, Horvath A, Birner-Gruenberger R, Spindelboeck W, Stadlbauer V, Taschler U, Curcic S, Stauber RE, Holzer M, Pasterk L, Heinemann A, and Marsche G
- Subjects
- Aged, Apolipoproteins E blood, Aryldialkylphosphatase blood, Bilirubin blood, Cholesterol, LDL blood, Creatinine blood, Cross-Sectional Studies, Cytokines biosynthesis, Cytokines metabolism, Female, Humans, Liver pathology, Liver physiopathology, Liver Cirrhosis pathology, Liver Cirrhosis physiopathology, Male, Middle Aged, Monocytes metabolism, Monocytes pathology, Serum Albumin metabolism, Serum Amyloid A Protein, Survival Analysis, Triglycerides blood, Apolipoprotein A-I blood, Apolipoprotein C-III blood, Apolipoproteins B blood, Cholesterol, HDL blood, Liver metabolism, Liver Cirrhosis blood
- Abstract
High-density lipoproteins (HDL) are important endogenous inhibitors of inflammatory responses. Functional impairment of HDL might contribute to the excess mortality experienced by patients with liver disease, but the effect of cirrhosis on HDL metabolism and function remain elusive. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function using apolipoprotein (apo) B-depleted sera from patients with compensated cirrhosis, patients with acutely decompensated cirrhosis and healthy controls. We observed that sera of cirrhotic patients showed reduced levels of HDL-cholesterol and profoundly suppressed activities of several enzymes involved in HDL maturation and metabolism. Native gel electrophoresis analyses revealed that cirrhotic serum HDL shifts towards the larger HDL2 subclass. Proteomic assessment of isolated HDL identified several proteins, including apoA-I, apoC-III, apoE, paraoxonase 1 and acute phase serum amyloid A to be significantly altered in cirrhotic patients. With regard to function, these alterations in levels, composition and structure of HDL were strongly associated with metrics of function of apoB-depleted sera, including cholesterol efflux capability, paraoxonase activity, the ability to inhibit monocyte production of cytokines and endothelial regenerative activities. Of particular interest, cholesterol efflux capacity appeared to be strongly associated with liver disease mortality. Our findings may be clinically relevant and improve our ability to monitor cirrhotic patients at high risk., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
38. Correction: High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration.
- Author
-
Pertl L, Kern S, Weger M, Hausberger S, Trieb M, Gasser-Steiner V, Haas A, Scharnagl H, Heinemann A, and Marsche G
- Abstract
[This corrects the article DOI: 10.1371/journal.pone.0154397.].
- Published
- 2016
- Full Text
- View/download PDF
39. High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration.
- Author
-
Pertl L, Kern S, Weger M, Hausberger S, Trieb M, Gasser-Steiner V, Haas A, Scharnagl H, Heinemann A, and Marsche G
- Subjects
- Aged, Animals, Anti-Inflammatory Agents pharmacology, Antioxidants metabolism, Aryldialkylphosphatase metabolism, Cholesterol metabolism, Demography, Humans, Mice, Oxidation-Reduction, Phospholipases A2 metabolism, RAW 264.7 Cells, Serum Amyloid A Protein metabolism, Lipoproteins, HDL blood, Wet Macular Degeneration blood
- Abstract
Purpose: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients., Methods: Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants., Results: In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-κB expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01)., Conclusions: The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis.
- Published
- 2016
- Full Text
- View/download PDF
40. Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.
- Author
-
Pasterk L, Lemesch S, Leber B, Trieb M, Curcic S, Stadlbauer V, Schuligoi R, Schicho R, Heinemann A, and Marsche G
- Subjects
- Adolescent, Adult, Advanced Oxidation Protein Products chemistry, Advanced Oxidation Protein Products pharmacology, Aged, Aged, 80 and over, Blood Platelets pathology, CD36 Antigens genetics, CD40 Ligand blood, CD40 Ligand genetics, Endothelial Cells pathology, Female, Gene Expression Regulation, Humans, Kidney Failure, Chronic genetics, Kidney Failure, Chronic pathology, Kidney Transplantation, Male, Middle Aged, Platelet Activation drug effects, Platelet Aggregation drug effects, Renal Dialysis, Serum Albumin chemistry, Serum Albumin pharmacology, Signal Transduction, Thromboplastin genetics, Thromboplastin metabolism, Advanced Oxidation Protein Products blood, Blood Platelets metabolism, CD36 Antigens blood, Endothelial Cells metabolism, Kidney Failure, Chronic blood, Serum Albumin metabolism
- Abstract
Plasma advanced oxidation protein products (AOPPs), a class of pro-inflammatory pathogenic mediators, accumulate in subjects with chronic kidney disease. Whether AOPPs contribute to coagulation abnormalities, which are frequently seen in uremic patients, is unknown. Here we report that AOPPs activate platelets via a CD36-mediated signaling pathway. Activation of signaling pathways by AOPP-platelet interaction resulted in the expression of several platelet activation markers and rapidly induced the expression of CD40 ligand, triggering platelet adhesion to endothelial cells and promoting endothelial tissue factor expression. AOPPs and serum tissue factor levels were considerably increased in end stage renal disease patients on hemodialysis and a significant correlation of AOPPs and serum tissue factor was found. Interestingly, serum levels of AOPPs and tissue factor were substantially lower in stable kidney transplant patients when compared with hemodialysis patients. Given that CD36 is known to transduce the effects of oxidized lipids into platelet hyperactivity, our findings reveal previously unknown pro-thrombotic activities of oxidized plasma albumin via a CD36 dependent pathway.
- Published
- 2016
- Full Text
- View/download PDF
41. Dialysis Modalities and HDL Composition and Function.
- Author
-
Holzer M, Schilcher G, Curcic S, Trieb M, Ljubojevic S, Stojakovic T, Scharnagl H, Kopecky CM, Rosenkranz AR, Heinemann A, and Marsche G
- Subjects
- 1-Alkyl-2-acetylglycerophosphocholine Esterase metabolism, Aged, Aryldialkylphosphatase metabolism, Case-Control Studies, Cells, Cultured, Cholesterol metabolism, Cholesterol Ester Transfer Proteins blood, Female, Humans, Kidney Failure, Chronic enzymology, Lipopolysaccharides pharmacology, Lipoprotein Lipase blood, Lipoproteins, HDL pharmacology, Macrophages metabolism, Male, Middle Aged, Monocytes drug effects, Monocytes metabolism, NF-kappa B metabolism, Peritoneal Dialysis, Phosphatidylcholine-Sterol O-Acyltransferase blood, Phospholipid Transfer Proteins blood, Triglycerides blood, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Lipoproteins, HDL blood, Lipoproteins, HDL chemistry, Renal Dialysis methods
- Abstract
Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD., (Copyright © 2015 by the American Society of Nephrology.)
- Published
- 2015
- Full Text
- View/download PDF
42. Anti-psoriatic therapy recovers high-density lipoprotein composition and function.
- Author
-
Holzer M, Wolf P, Inzinger M, Trieb M, Curcic S, Pasterk L, Weger W, Heinemann A, and Marsche G
- Subjects
- Administration, Topical, Adult, Aged, Antigens, Human Platelet metabolism, Aryldialkylphosphatase metabolism, Cardiovascular Diseases metabolism, Cardiovascular Diseases mortality, Cholesterol pharmacokinetics, Female, Humans, Lipolysis drug effects, Lipolysis physiology, Male, Middle Aged, Phosphatidylcholine-Sterol O-Acyltransferase metabolism, Psoriasis immunology, Risk Factors, Tritium, Lipoproteins, HDL blood, Macrophages metabolism, PUVA Therapy, Psoriasis drug therapy, Psoriasis metabolism
- Abstract
Psoriasis is a chronic inflammatory disorder associated with increased cardiovascular mortality. Psoriasis affects high-density lipoprotein (HDL) composition, generating dysfunctional HDL particles. However, data regarding the impact of anti-psoriatic therapy on HDL composition and function are not available. HDL was isolated from 15 psoriatic patients at baseline and after effective topical and/or systemic anti-psoriatic therapy and from 15 age- and sex-matched healthy controls. HDL from psoriatic patients showed a significantly impaired capability to mobilize cholesterol from macrophages (6.4 vs. 8.0% [(3)H]cholesterol efflux, P<0.001), low paraoxonase (217 vs. 350 μM(-1) minute(-1) mg(-1) protein, P=0.011) and increased Lp-PLA2 activities (19.9 vs. 12.1 nM(-1) minute(-1) mg(-1) protein, P=0.028). Of particular interest, the anti-psoriatic therapy significantly improved serum lecithin-cholesterol acyltransferase activity and decreased total serum lipolytic activity but did not affect serum levels of HDL-cholesterol. Most importantly, these changes were associated with a significantly improved HDL-cholesterol efflux capability. Our results provide evidence that effective anti-psoriatic therapy recovers HDL composition and function, independent of serum HDL-cholesterol levels, and support to the emerging concept that HDL function may be a better marker of cardiovascular risk than HDL-cholesterol levels.
- Published
- 2014
- Full Text
- View/download PDF
43. Aging affects high-density lipoprotein composition and function.
- Author
-
Holzer M, Trieb M, Konya V, Wadsack C, Heinemann A, and Marsche G
- Subjects
- Adult, Aged, Aging metabolism, Antioxidants metabolism, Aryldialkylphosphatase metabolism, Carboxylic Ester Hydrolases metabolism, Cholesterol metabolism, Female, Humans, Lipoproteins, HDL blood, Macrophages metabolism, Male, Serum Amyloid A Protein metabolism, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Aging pathology, Lipoproteins, HDL chemistry
- Abstract
Most coronary deaths occur in patients older than 65years. Age associated alterations in the composition and function of high-density lipoproteins (HDL) may contribute to cardiovascular mortality. The effect of advanced age on the composition and function of HDL is not well understood. HDL was isolated from healthy young and elderly subjects. HDL composition, cellular cholesterol efflux/uptake, anti-oxidant properties and paraoxonase activity were assessed. We observed a 3-fold increase of the acute phase protein serum amyloid A, an increased content of complement C3 and proteins involved in endopeptidase/protease inhibition in HDL of elderly subjects, whereas levels of apolipoprotein E were significantly decreased. HDL from elderly subjects contained less cholesterol but increased sphingomyelin. Most importantly, HDL from elderly subjects showed defective antioxidant properties, lower paraoxonase 1 activity and was more rapidly taken up by macrophages, whereas cholesterol efflux capability was not altered. These findings suggest that aging alters HDL composition, resulting in functional impairment that may contribute to the onset/progression of cardiovascular disease., (Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
44. Transcriptional profiling of C. elegans DAF-19 uncovers a ciliary base-associated protein and a CDK/CCRK/LF2p-related kinase required for intraflagellar transport.
- Author
-
Phirke P, Efimenko E, Mohan S, Burghoorn J, Crona F, Bakhoum MW, Trieb M, Schuske K, Jorgensen EM, Piasecki BP, Leroux MR, and Swoboda P
- Subjects
- Animals, Animals, Genetically Modified, Biological Transport, Caenorhabditis elegans metabolism, Caenorhabditis elegans Proteins genetics, Caenorhabditis elegans Proteins metabolism, Cyclin-Dependent Kinases genetics, Cyclin-Dependent Kinases metabolism, Gene Expression Profiling, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Mutation, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Sensory Receptor Cells metabolism, Transcription Factors metabolism, Transcription, Genetic, Caenorhabditis elegans genetics, Caenorhabditis elegans Proteins physiology, Cilia metabolism, Cyclin-Dependent Kinases physiology, Protein Serine-Threonine Kinases physiology, Transcription Factors genetics
- Abstract
Cilia are ubiquitous cell surface projections that mediate various sensory- and motility-based processes and are implicated in a growing number of multi-organ genetic disorders termed ciliopathies. To identify new components required for cilium biogenesis and function, we sought to further define and validate the transcriptional targets of DAF-19, the ciliogenic C. elegans RFX transcription factor. Transcriptional profiling of daf-19 mutants (which do not form cilia) and wild-type animals was performed using embryos staged to when the cell types developing cilia in the worm, the ciliated sensory neurons (CSNs), still differentiate. Comparisons between the two populations revealed 881 differentially regulated genes with greater than a 1.5-fold increase or decrease in expression. A subset of these was confirmed by quantitative RT-PCR. Transgenic worms expressing transcriptional GFP fusions revealed CSN-specific expression patterns for 11 of 14 candidate genes. We show that two uncharacterized candidate genes, termed dyf-17 and dyf-18 because their corresponding mutants display dye-filling (Dyf) defects, are important for ciliogenesis. DYF-17 localizes at the base of cilia and is specifically required for building the distal segment of sensory cilia. DYF-18 is an evolutionarily conserved CDK7/CCRK/LF2p-related serine/threonine kinase that is necessary for the proper function of intraflagellar transport, a process critical for cilium biogenesis. Together, our microarray study identifies targets of the evolutionarily conserved RFX transcription factor, DAF-19, providing a rich dataset from which to uncover-in addition to DYF-17 and DYF-18-cellular components important for cilium formation and function., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
45. M.TaqI facilitates the base flipping via an unusual DNA backbone conformation.
- Author
-
Wibowo FR, Rauch C, Trieb M, and Liedl KR
- Subjects
- Adenine chemistry, Base Pairing, Base Sequence, Computer Simulation, CpG Islands, Crystallography, X-Ray, DNA, Bacterial metabolism, DNA-Binding Proteins metabolism, Methylation, Models, Molecular, Molecular Structure, Nucleotides chemistry, Phosphates chemistry, Site-Specific DNA-Methyltransferase (Adenine-Specific) metabolism, Substrate Specificity, Thermodynamics, Thermus enzymology, Thymine chemistry, Time Factors, DNA, Bacterial chemistry, Nucleic Acid Conformation, Site-Specific DNA-Methyltransferase (Adenine-Specific) chemistry
- Abstract
MD simulations have been carried out to understand the dynamical behavior of the DNA substrate of the Thermus aquaticus DNA methyltransferase (M.TaqI) in the methylation process at N6 of adenine. As starting structures, an x-ray structure of M.TaqI in complex with DNA and cofactor analogue (PDB code: 1G 38) and free decamer d(GTTCGATGTC)(2) were taken. The x-ray structure shows two consecutive BII substates that are not observed in the free decamer. These consecutive BII substates are also observed during our simulation. Additionally, their facing backbones adopt the same conformations. These double facing BII substates are stable during the last 9 ns of the trajectories and result in a stretched DNA structure. On the other hand, protein-DNA contacts on 5' and 3' phosphodiester groups of the partner thymine of flipped adenine have changed. The sugar and phosphate parts of thymine have moved further into the empty space left by the flipping base without the influence of protein. Furthermore, readily high populated BII substates at the GpA step of palindromic tetrad TCGA rather than CpG step are observed in the free decamer. On the contrary, the BI substate at the GpA step is observed on the flipped adenine strand. A restrained MD simulation, reproducing the BI/BII pattern in the complex, demonstrated the influence of the unusual backbone conformation on the dynamical behavior of the target base. This finding along with the increased nearby interstrand phosphate distance is supportive to the N6-methylation mechanism., ((c) 2005 Wiley Periodicals, Inc. Biopolymers 79: 128-138, 2005.)
- Published
- 2005
- Full Text
- View/download PDF
46. Towards an understanding of DNA recognition by the methyl-CpG binding domain 1.
- Author
-
Rauch C, Trieb M, Wibowo FR, Wellenzohn B, Mayer E, and Liedl KR
- Subjects
- 5-Methylcytosine metabolism, Amino Acid Sequence, Asparagine chemistry, Asparagine metabolism, Computer Simulation, Conserved Sequence, DNA chemistry, Epigenesis, Genetic, Humans, Methane metabolism, Molecular Structure, Nuclear Magnetic Resonance, Biomolecular, Protein Conformation, Protein Structure, Secondary, Protein Structure, Tertiary, Thermodynamics, DNA genetics, DNA metabolism, DNA Methylation, DNA-Binding Proteins chemistry, DNA-Binding Proteins metabolism, Methane analogs & derivatives, Transcription Factors chemistry, Transcription Factors metabolism
- Abstract
CpG methylation determines a variety of biological functions of DNA. The methylation signal is interpreted by proteins containing a methyl-CpG binding domain (MBDs). Based on the NMR structure of MBD1 complexed with methylated DNA we analysed the recognition mode by means of molecular dynamics simulations. As the protein is monomeric and recognizes a symmetrically methylated CpG step, the recognition mode is an asymmetric one. We find that the two methyl groups do not contribute equally to the binding energy. One methyl group is associated with the major part of the binding energy and the other one nearly does not contribute at all. The contribution of the two cytosine methyl groups to binding energy is calculated to be -3.6 kcal/mol. This implies a contribution of greater than two orders of magnitude to the binding constant. The conserved amino acid Asp32 is known to be essential for DNA binding by MBD1, but so far no direct contact with DNA has been observed. We detected a direct DNA base contact to Asp32. This could be the main reason for the importance of this amino acid. MBD contacts DNA exclusively in the major groove, the minor groove is reserved for histone contacts. We found a deformation of the minor groove shape due to complexation by MBD1, which indicates an information transfer between the major and the minor groove.
- Published
- 2005
- Full Text
- View/download PDF
47. Z-DNA's conformer substates revealed by FT-IR difference spectroscopy of nonoriented left-handed double helical poly(dG-dC).
- Author
-
Rauch C, Pichler A, Trieb M, Wellenzohn B, Liedl KR, and Mayer E
- Subjects
- DNA, Z-Form chemistry, Data Interpretation, Statistical, Kinetics, Nucleic Acid Conformation, Spectroscopy, Fourier Transform Infrared, Spectrum Analysis, Raman, Temperature, DNA, Z-Form metabolism, Polydeoxyribonucleotides chemistry
- Abstract
Nonoriented hydrated films of double helical poly(dG-dC) in the Z-form were studied by Fourier transform infrared (FT-IR) spectroscopy either as equilibrated slow-cooled samples between 290 and 220 K or, after quenching into the glassy state, as nonequilibrated film isothermally at 200, 220, and 240 K. IR spectral changes on isothermal relaxation at 200 and 220 K toward equilibrium, caused by interconversion of two conformer substates (CS) called Z1 and Z2, are revealed by IR difference spectra. Pronounced spectral changes on Z1-to-Z2 interconversion occur between approximately 750-1250 cm(-1) and these are attributed to structural changes of the phosphodiester-sugar backbone caused by changes of torsion angles, and to decreasing hydrogen-bonding of the ionic phosphate group with water molecules. These spectral changes on Z1-to-Z2 transition can be related to structural differences between ZI and ZII CS observed in single crystals. ZI/ZII CS occurs only at (dGpdC) base steps, and similar behavior is assumed for Z1/Z2. The Z1/Z2 population ratio was determined via curve resolution of marker bands for Z1 and Z2 centered at 785 and 779 cm(-1). This ratio is 0.64 at 290 K, corresponding to 39% of the phosphates of the (dGpdC) base steps in Z1 and 61% in Z2, and it increases to 1.24 on cooling to 220 K. For the Z2<=>Z1 equilibrium, an enthalpy change of -4.9 +/- 0.2 kJ mol(dGpdC)(-1) is obtained from the temperature dependence of the equilibrium constant. Z1 interconverts into Z2 at isothermal relaxation at 200 and 220 K, whereas on slow cooling from ambient temperature, Z2 interconverts into Z1. This unexpected reversal of CS interconversion is attributed to slow restructuring of hydration shells of the CS on quenching, in the same manner reported by Pichler et al. for the BI and BII CS of B-DNA (J. Phys. Chem. B 106, 3263-3274 (2002)). IR difference curves demonstrate two time scales on isothermal relaxation of Z1-->Z2 interconversion, a fast one for structural relaxation of the sugar-phosphate backbone, and a slow one for relaxation of the hydration shells. This slowing down of restructuring of CS hydration shells at approximately 220-240 K could be the cause for the suppression of biological functions at low temperatures.
- Published
- 2005
- Full Text
- View/download PDF
48. The N6-methyl group of adenine further increases the BI stability of DNA compared to C5-methyl groups.
- Author
-
Wibowo FR, Trieb M, Rauch C, Wellenzohn B, and Liedl KR
- Subjects
- Models, Molecular, Molecular Structure, Adenine chemistry, Computer Simulation, DNA chemistry
- Abstract
Methylated DNA bases are natural modifications which play an important role in protein-DNA interactions. Recent experimental and theoretical results have shown an influence of the base modification on the conformational behavior of the DNA backbone. MD simulations of four different B-DNA dodecamers (d(GC)(6), d(AT)(6), d(G(5mCG)(5)C), and d(A(T6mA)(5)T)) have been performed with the aim to examine the influence of methyl groups on the B-DNA backbone behavior. An additional control simulation of d(AU)(6) has also been performed to examine the further influence of the C5-methyl group in thymine. Methyl groups in the major groove (as in C5-methylcytosine, thymine, or N6-methyladenine) decrease the BII substate population of RpY steps. Due to methylation a clearer distinction of the BI substate stability between YpR and RpY (CpG/GpC or TpA/ApT) steps arises. A positive correlation between the BII substate population and base stacking distances is seen only for poly(GC). A methyl group added into the major groove increases mean water residence times around the purine N7 atom, which may stabilize the BI substate by improving the hydration network between the DNA backbone and the major groove. The N6-methyl group also forms a water molecule bridge between the N6 and O4 atoms, and thus further stabilizes the BI substate.
- Published
- 2005
- Full Text
- View/download PDF
49. Water-mediated contacts in the trp-repressor operator complex recognition process.
- Author
-
Wibowo FR, Rauch C, Trieb M, Wellenzohn B, and Liedl KR
- Subjects
- Base Pairing, Base Sequence, Binding Sites, Computer Simulation, DNA chemistry, DNA metabolism, Hydrogen Bonding, Models, Molecular, Nucleic Acid Conformation, Repressor Proteins metabolism, Operator Regions, Genetic, Repressor Proteins chemistry, Water chemistry
- Abstract
Water-mediated contacts are known as an important recognition tool in trp-repressor operator systems. One of these contacts involves two conserved base pairs (G(6).C(-6) and A(5). T(-5)) and three amino acids (Lys 72, Ile 79, and Ala 80). To investigate the nature of these contacts, we analyzed the X-ray structure (PDB code: 1TRO) of the trp-repressor operator complex by means of molecular dynamics simulations. This X-ray structure contains two dimers that exhibit structural differences. From these two different starting structures, two 10 ns molecular dynamics simulations have been performed. Both of our simulations show an increase of water molecules in the major groove at one side of the dimer, while the other side remains unchanged compared to the X-ray structure. Though the maximum residence time of the concerned water molecules decreases with an increase of solvent at the interface, these water molecules continue to play an important role in mediating DNA-protein contacts. This is shown by new stable amino acids-DNA distances and a long water residence time compared to free DNA simulation. To maintain stability of the new contacts, the preferential water binding site on O6(G6) is extended. This extension agrees with mutation experiment data on A5 and G6, which shows different relative affinity due to mutation on these bases [A. Joachimiak, T. E. Haran, P. B. Sigler, EMBO Journal 1994, Vol. 13, No. (2) pp. 367-372]. Due to the rearrangements in the system, the phosphate of the base G6 is able to interconvert to the B(II) substate, which is not observed on the other half side of the complex. The decrease of the number of hydrogen bonds between protein and DNA backbone could be the initial step of the dissociation process of the complex, or in other words an intermediate complex conformation of the association process. Thus, we surmise that these features show the importance of water-mediated contacts in the trp-repressor operator recognition process., (Copyright 2004 Wiley Periodicals, Inc.)
- Published
- 2004
- Full Text
- View/download PDF
50. Daunomycin intercalation stabilizes distinct backbone conformations of DNA.
- Author
-
Trieb M, Rauch C, Wellenzohn B, Wibowo F, Loerting T, Mayer E, and Liedl KR
- Subjects
- Binding Sites, Computer Simulation, Crystallography, X-Ray, DNA chemistry, Daunorubicin chemistry, Models, Molecular, Time Factors, DNA drug effects, Daunorubicin pharmacology, Intercalating Agents pharmacology, Nucleic Acid Conformation drug effects
- Abstract
Daunomycin is a widely used antibiotic of the anthracycline family. In the present study we reveal the structural properties and important intercalator-DNA interactions by means of molecular dynamics. As most of the X-ray structures of DNA-daunomycin intercalated complexes are short hexamers or octamers of DNA with two drug molecules per doublehelix we calculated a self complementary 14-mer oligodeoxyribonucleotide duplex d(CGCGCGATCGCGCG)2 in the B-form with two putative intercalation sites at the 5'-CGA-3' step on both strands. Consequently we are able to look at the structure of a 1:1 complex and exclude crystal packing effects normally encountered in most of the X-ray crystallographic studies conducted so far. We performed different 10 to 20 ns long molecular dynamics simulations of the uncomplexed DNA structure, the DNA-daunomycin complex and a 1:2 complex of DNA-daunomycin where the two intercalator molecules are stacked into the two opposing 5'-CGA-3' steps. Thereby--in contrast to X-ray structures--a comparison of a complex of only one with a complex of two intercalators per doublehelix is possible. The chromophore of daunomycin is intercalated between the 5'-CG-3' bases while the daunosamine sugar moiety is placed in the minor groove. We observe a flexibility of the dihedral angle at the glycosidic bond, leading to three different positions of the ammonium group responsible for important contacts in the minor groove. Furthermore a distinct pattern of BI and BII around the intercalation site is induced and stabilized. This indicates a transfer of changes in the DNA geometry caused by intercalation to the DNA backbone.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.